Aclaris Therapeutics (ACRS) Enterprise Value Growth (1y) (2015 - 2026)
Aclaris Therapeutics (ACRS) Enterprise Value Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aclaris Therapeutics | 705.88 Mn | 705.88 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.10% |
| Dec 31, 2025 | 20.11% |
| Sep 30, 2025 | 24.91% |
| Jun 30, 2025 | 10.16% |
| Mar 31, 2025 | 17.83% |
| Dec 31, 2024 | 4.63% |
| Sep 30, 2024 | -23.94% |
| Jun 30, 2024 | 7.25% |
| Mar 31, 2024 | 24.96% |
| Dec 31, 2023 | 45.26% |
| Sep 30, 2023 | 58.46% |
| Jun 30, 2023 | 51.82% |
| Mar 31, 2023 | 4.91% |
| Dec 31, 2022 | -13.67% |
| Sep 30, 2022 | -25.36% |
| Jun 30, 2022 | -7.31% |
| Mar 31, 2022 | -40.01% |
| Dec 31, 2021 | -253.61% |
| Sep 30, 2021 | -258.29% |
| Jun 30, 2021 | -240.12% |